Listen To The Story
Marketplace

More patients who are terminally ill will potentially have access to experimental drugs under a measure passed by the House last night. President Donald Trump is expected to sign the so-called "right-to-try" bill. Forty states have already passed similar legislation. Currently, terminal patients not covered by those laws have only two options for getting unapproved drugs: They can enroll in clinical trials if they're eligible or apply for experimental treatment through the FDA's "expanded access" program. Proponents of the measure say the additional choice gives hope to patients who have exhausted other options. But the new law wouldn't necessarily guarantee access.

Click the audio player above to hear the full story. 

As a nonprofit news organization, Marketplace is on a mission that drives what we do every day: to increase economic intelligence across the country. But we can’t do it alone. Become a Marketplace Investor today, in whatever amount you choose, and your donation will go twice as far, thanks to a dollar-for-dollar match from The Kendeda Fund.

Become a Marketplace Investor today – in whatever amount is right for you – and keep public service journalism strong. We’re grateful for your support.

Follow Amy Scott at @amyreports